Patents Examined by Paul M. Coughlan, Jr.
  • Patent number: 4483857
    Abstract: 2,4-Diaminoquinazoline compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof wherein R is a pyrimidinyl, pyrazinyl, pyridazinyl or triazinyl group linked to the piperazine ring by one of its carbon atoms, and optionally substituted by hydroxy, halogen, alkyl, aralkyl, alkoxy, aralkoxy, alkylthio, aryl, aryloxy and certain amino groups; their use as an antihypertensive agent and pharmaceutical compositions containing them.
    Type: Grant
    Filed: August 24, 1983
    Date of Patent: November 20, 1984
    Assignee: Pfizer Inc.
    Inventors: Simon F. Campbell, Rhona M. Plews
  • Patent number: 4482551
    Abstract: There is presented compounds of the formula ##STR1## in which R.sup.1 represents hydrogen or methyl, as well as readily hydrolyzable esters and salts of these compounds and the hydrates thereof.Also presented are various intermediates and a process to produce the novel derivatives.The acyl derivatives have pharmacological activity as antibacterial agents.
    Type: Grant
    Filed: July 30, 1982
    Date of Patent: November 13, 1984
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Andre Furlenmeier, Paul Lanz
  • Patent number: 4482553
    Abstract: 7-(2-Benzothienyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: November 13, 1984
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bernard J. Graves, Edward R. Lavagnino
  • Patent number: 4482710
    Abstract: The acetoxymethyl group at the 3-position of 3-acetoxymethylcephalosporanic acids and salts thereof may be replaced by an alkoxymethyl group, by reacting the 3-acetoxymethylcephalosporanic acid or salt thereof with a C.sub.1 -C.sub.4 alkanol in the presence of halide ions.
    Type: Grant
    Filed: November 30, 1982
    Date of Patent: November 13, 1984
    Assignee: Sankyo Company Limited
    Inventors: Koichi Fujimoto, Eiji Nakayama, Hideo Nakao
  • Patent number: 4482560
    Abstract: Novel carbostyril derivatives and their salts having antihistaminic effects and are useful as antihistaminic agents, represented by the general formula (1), ##STR1## wherein R.sup.1 is a hydrogen atom, a lower alkenyl group, a lower alkynyl group or a lower alkyl group which may have phenyl group(s) as the substituted group(s); R.sup.2 is a hydrogen atom, a lower alkyl group or a phenyl group; R.sup.3 is a lower alkyl group having phenyl group(s) as the substituted group(s), or a phenyl group which may have 1 to 3 substituted groups selected from the group consisting of halogen atoms, lower alkyl groups and lower alkoxy groups; R.sup.4 is a hydrogen atom, a hydroxyl group or a lower alkanoyl group; X is a halogen atom; Y is a lower alkylene group which may have hydroxyl group(s) as the substituent(s); n is 0, 1 or 2; the carbon-carbon bond between 3- and 4-positions in the carbostyril skeleton is a single or double bond; provided that when R.sup.
    Type: Grant
    Filed: March 12, 1982
    Date of Patent: November 13, 1984
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Kazuo Banno, Takafumi Fujioka, Yasuo Oshiro, Kazuyuki Nakagawa
  • Patent number: 4479963
    Abstract: 1-Carboxy-(alkanoyl or aralkanoyl)-indoline-2-carboxylic acids, e.g., those of the formula ##STR1## R=H, alkyl, alkoxy, halogeno or CF.sub.3 ; R'=H or R-phenyl;m=0 or 1;p,q=0 to 2;and derivatives thereof, are antihypertensive and cardioactive agents.
    Type: Grant
    Filed: April 26, 1982
    Date of Patent: October 30, 1984
    Assignee: Ciba-Geigy Corporation
    Inventor: Norbert Gruenfeld
  • Patent number: 4478835
    Abstract: Substituted imidazo[1,5-c]pyrimidines have been found to have potent bronchodilator activity. Pharmacological methods, pharmaceutical compositions and synthetic intermediates are also disclosed.
    Type: Grant
    Filed: August 2, 1983
    Date of Patent: October 23, 1984
    Assignee: Riker Laboratories, Inc.
    Inventor: James J. Wade
  • Patent number: 4477447
    Abstract: This invention relates to novel 7-acylaminocephalosporanic acid derivatives of high antimicrobial activity, to processes for their preparation, and to pharmaceutical compositions comprising said derivatives, said derivatives being of the formula: ##STR1## wherein R.sup.1 is amino or protected amino,R.sup.2 is dialkanoyloxy(lower)alkyl; alkyl having one or more substituents selected from the group consisting of hydroxy, protected hydroxy, alkoxy, carboxy, protected carboxy, cycloalkylcarbonyloxy and heterocyclic group; lower alkoxycarbonyloxy(lower)alkyl; azido(lower)alkoxycarbonyloxy(lower)alkyl; aroyloxy(lower)alkyl; higher alkanoyloxy(lower)alkyl; phthalidyl; or phthalidylidene(lower)alkyl,R.sup.3 is lower alkyl,Y is thio (--S--) or sulfinyl (--S--), and the dotted line represents 2- or 3-cephem nuclei.
    Type: Grant
    Filed: February 24, 1982
    Date of Patent: October 16, 1984
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Ikuo Ueda, Tsutomu Teraji, Takao Takaya, Keiji Takai, Hisashi Takasugi, Fumio Shimojo, Shigetaka Nishino
  • Patent number: 4477614
    Abstract: 2-[2-Hydroxy-3,5-di-tert-octylphenyl]-2H-benzotriazole exhibits outstanding efficacy in protecting organic substrates from light induced deterioration as well as good resistance to loss by volatilization or exudation during the high temperature processing of stabilized compositions.
    Type: Grant
    Filed: April 12, 1982
    Date of Patent: October 16, 1984
    Assignee: Ciba-Geigy Corporation
    Inventors: Martin Dexter, Roland A. E. Winter
  • Patent number: 4477660
    Abstract: This invention encompasses 7-(S)-acylamino-3-acetoxymethyl-3-cephem-4-carboxylic acid sulfones and the epimerization process for making them. The epimerization process employs an organic nitrogen base reagent having a pKa between about 9.0 to about 11.5. The compounds of this invention are intermediates in the synthesis of 1-oxa-.beta.-lactam antibiotics.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: October 16, 1984
    Assignee: Eli Lilly and Company
    Inventor: David A. Hall
  • Patent number: 4477378
    Abstract: Disclosed are esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1-H-3-benzazepines represented by the general formula I ##STR1## wherein X is chloro, bromo or trifluoromethyl; R.sub.1 is alkyl, aralkyl, aryl, alkoxyalkyl, aryloxyalkyl, aralkoxyalkyl, cycloalkylalkyl, alkoxycarbonylalkyl, cycloalkyl, 1-adamantyl, cycloalkoxyalkyl, alkoxy, aralkoxy, cycloalkoxy or aryloxy; and the pharmaceutically acceptable acid addition salts thereof. The compounds show neuroleptic, antidepressive and antiaggressive activity.
    Type: Grant
    Filed: September 9, 1982
    Date of Patent: October 16, 1984
    Assignee: Schering Corp.
    Inventors: Elijah H. Gold, Wei K. Chang
  • Patent number: 4476306
    Abstract: 2,4-Dihydroxypyrimidine (uracil) is prepared from alkali formyl acetic acid ester by reaction with thiourea, heating with chloroacetic acid, and heating with acids.
    Type: Grant
    Filed: July 23, 1982
    Date of Patent: October 9, 1984
    Assignee: Dynamit Nobel AG
    Inventor: Hermann Peeters
  • Patent number: 4476122
    Abstract: Novel alkyloximes of 7-amino-thiazolyl-acetamido-cephalosporanic acids of the formula ##STR1## wherein R is selected from the group consisting of alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 5 carbon atoms and --CH.sub.2 --SR', R' is selected from the group consisting of acyl of an alkanoic acid of 2 to 4 carbon atoms, 1-methyl-tetrazolyl and 2-methyl-1,3,4-thiadiazolyl, R.sub.1 is selected from the group consisting of hydrogen and a group easily removeable by acid hydrolysis or hydrogenolysis, R.sub.2 is selected from the group consisting of alkyl of 1 to 4 carbon atoms and alkenyl and alkynyl of 2 to 4 carbon atoms, A is selected from the group consisting of hydrogen, an alkali metal cation, an equivalent of an alkaline earth metal or magnesium, or organic amine base cation and an ester group easily removeable by acid hydrolysis or hydrogenolysis with the proviso that when R.sub.1 is hydrogen, A is not an ester group easily removeable by hydrogenolysis or acid hydrolysis and the wavy line means that OR.
    Type: Grant
    Filed: December 13, 1978
    Date of Patent: October 9, 1984
    Assignee: Roussel Uclaf
    Inventors: Rene Heymes, Andre Lutz
  • Patent number: 4476310
    Abstract: A process for the preparation of indoles which comprises reacting aniline or a derivative thereof with a 1,2-glycol in the presence of a catalyst comprising silver supported on a carrier having a specific surface area of not less than 10 m.sup.2 /g.
    Type: Grant
    Filed: June 9, 1982
    Date of Patent: October 9, 1984
    Assignee: Mitsui Toatsu Chemicals, Inc.
    Inventors: Tadatoshi Honda, Fujio Matsuda, Tadamitsu Kiyoura, Kazuhiro Terada
  • Patent number: 4476123
    Abstract: The present invention relates to derivatives of the family of cephalosporins, of formula: ##STR1## in which ##STR2## is an acid, a salt or an ester of this acid, R.sub.1 is a group of form ##STR3## in which R.sub.A and R.sub.B are H or alkyl or form a saturated cyclobutyl or cyclopentyl ring and R.sub.C is H or COOH, R.sub.2 is a thiazolium salt or a OCOCH.sub.2 R.sub.D group in which R.sub.D is a 1,3-thiazol-4-yl group.The invention also relates to a process for preparing the products of formula (I) and to drugs containing said products.
    Type: Grant
    Filed: March 2, 1982
    Date of Patent: October 9, 1984
    Assignee: Sanofi
    Inventors: Bernard Labeeuw, Ali Salhi
  • Patent number: 4474792
    Abstract: Amides obtained by condensing aminotetrazole with optionally substituted ortho-alkoxybenzoic and ortho-methylthiobenzoic acids are potent anti-allergic agents.
    Type: Grant
    Filed: December 3, 1981
    Date of Patent: October 2, 1984
    Assignee: Riker Laboratories, Inc.
    Inventor: Edward H. Erickson
  • Patent number: 4474779
    Abstract: Cephalosporin compounds represented by the general formula ##STR1## wherein R represents a group shown by formula ##STR2## wherein R.sup.1 represents a hydrogen atom or a lower alkyl group of 1-3 carbon atoms and R.sup.2 represents a hydrogen atom, a lower alkyl group of 1-3 carbon atoms, a phenyl group which may be substituted by an amino or hydroxy group, a cyano group, a carboxy group, or a carboxymethyl group; said R.sup.1 and R.sup.2 may form a cycloalkylidene group of 4-6 carbon atoms together with the carbon atom to which they are bonded) or a group shown by formula --CH.sub.2 --R.sup.3 (wherein R.sup.3 represents a hydrogen atom, a halogenomethyl group, a carbamoyl group, a carboxymethyl group, .alpha.4-carboxy-3-hydroxyisothiazol-5-yl-thiomethyl group, or .alpha.2-carboxyphenylthiomethyl group); R' represents a group shown by formula ##STR3## (wherein R.sub.a represents a carboxy group, a cyano group, or a carbamoyl group which may be substituted by a lower alkyl group of 1-3 carbon atoms and R.sub.
    Type: Grant
    Filed: October 7, 1982
    Date of Patent: October 2, 1984
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Noriaki Nagano, Kohji Nakano, Tadao Shibanuma, Yukiyasu Murakami
  • Patent number: 4474788
    Abstract: There are described compounds of formula I, ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.7, which may be the same or different, each represent hydrogen, hydroxy, alkyl Cl to 6, alkoxy C1 to 6, amino, acyl C2 to 6, acylamino C2 to 6, alkenyl C2 to 6, halogen, or alkoxy C1 to 6 substituted by phenyl,X is a hydrocarbon chain of 1 to 10 carbon atoms optionally substituted by a hydroxy group,A is --Q--COOH,Q is absent or represents a straight or branched alkylene, alkenylene or alkynylene group of up to and including 6 carbon atoms,R.sub.8 and R.sub.9, which may be the same or different, each represent hydrogen or alkyl C1 to 6 or together form a single bond,D, Y and Z, which may be th same or different, each represent sulphur, oxygen or --NR.sub.10 --, andR.sub.10 is hydrogen or alkyl C1-C6,provided that(i) when D, Z and Y are all oxygen, R.sub.8 and R.sub.9 do not together form a single bond,(ii) when D is oxygen, R.sub.8 and R.sub.9 together form a single bond, X is (CH.sub.2).sub.
    Type: Grant
    Filed: November 1, 1982
    Date of Patent: October 2, 1984
    Assignee: Fisons plc
    Inventor: John R. Bantick
  • Patent number: 4474960
    Abstract: A process is disclosed for the preparation of racemic cis or trans apovincaminic acid esters of the formula (I) ##STR1## and the corresponding optically active derivatives of the formulae (Ia) ##STR2## wherein R.sup.1 and R.sup.2 are identical or different alkyl groups having 1 to 6 carbon atoms. Apovincaminic acid alkyl esters are well-known vasodilating compounds.
    Type: Grant
    Filed: June 11, 1982
    Date of Patent: October 2, 1984
    Assignee: Richter Gedeon Vegyeszeti Gyar Rt.
    Inventors: Csaba Szantay, Lajos Szabo, Gyorgy Kalaus, Janos Kreidl, Laszlo Czibula, Gyorgy Visky, Andras Nemes, Maria Farkas nee Kirlyak
  • Patent number: 4474780
    Abstract: 7-(D-2-Naphthylglycylamido)-3-methyl-3-cephem-4-carboxylic acid tetrahydrate is a stable crystal form of a potent orally active gram positive antibiotic.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: October 2, 1984
    Assignee: Eli Lilly and Company
    Inventor: Byron W. Daugherty